Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study.

C H Kon1, R H Asaria, N L Occleston

  • 1Vitreoretinal and Glaucoma Units, Moorfields Eye Hospital, and Wound Healing Research Unit, Department of Pathology, Institute of Ophthalmology, London, UK. chee@private.nethead.co.uk

The British Journal of Ophthalmology
|April 27, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stratifying the risk of re-detachment: variables associated with outcome of vitrectomy for rhegmatogenous retinal detachment in a large UK cohort study.

Eye (London, England)·2023
Same author

Prospects for the application of Müller glia and their derivatives in retinal regenerative therapies.

Progress in retinal and eye research·2021
Same author

Factors affecting visual recovery after successful repair of macula-off retinal detachments: findings from a large prospective UK cohort study.

Eye (London, England)·2020
Same author

Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort.

Eye (London, England)·2020
Same author

Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study).

Eye (London, England)·2017
Same author

Delayed atrophy of the retinal pigment epithelium after submacular surgery.

European journal of ophthalmology·2017

Preoperative proliferative vitreoretinopathy (PVR), aphakia, and high vitreous protein levels are key risk factors for developing postoperative PVR. These findings aid in identifying patients for potential treatment.

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Vitreoretinal Diseases

Background:

  • Proliferative vitreoretinopathy (PVR) is a significant cause of vision loss after retinal detachment surgery.
  • Identifying predictive risk factors for PVR is crucial for improving surgical outcomes.

Purpose of the Study:

  • To evaluate clinical variables and vitreous protein concentration as predictors of postoperative PVR.
  • To develop models for identifying patients at high risk of developing PVR.

Main Methods:

  • Prospective study of 140 patients undergoing primary vitrectomy for rhegmatogenous retinal detachment.
  • Recorded 12 clinical variables and measured vitreous protein concentration.
  • Utilized univariate and multivariate logistic regression analysis.

Related Experiment Videos

Main Results:

  • 40 of 136 patients (29.4%) developed postoperative PVR.
  • Significant independent risk factors identified: preoperative PVR (OR 3.01), aphakia (OR 2.72), and high vitreous protein (OR 1.11).
  • Silicone oil use and detachment size were significant in univariate but not multivariate analysis.

Conclusions:

  • Preoperative PVR, aphakia, and high vitreous protein levels are significant independent predictors of postoperative PVR.
  • Developed predictive models incorporating clinical factors and vitreous protein to identify at-risk patients.
  • These models may guide prophylactic intravitreal pharmacological interventions.